Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma

Ciclesonide for the Therapy of Asthma During the Cold Season.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00608218

Acronym

ARTIST

Enrollment

2100

Registered

2008-02-06

Start date

2008-01-31

Completion date

2008-08-31

Last updated

2016-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Asthma, ciclesonide, inhaled steroids, Alvesco

Brief summary

The aim of the study is to evaluate the efficacy of ciclesonide in patients with persistent asthma over 3 months, especially in the cold season. Ciclesonide will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of ciclesonide.

Interventions

DRUGCiclesonide

This is an observational study. Therefore, the physician decides about dosage according to individual needs.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

12 Years to No maximum

Healthy volunteers

Inclusion criteria

Main inclusion criteria: * History of persistent bronchial asthma Main

Exclusion criteria

* Hypersensitive to compounds of Alvesco * Other criteria as defined in the Summary of Product Characteristics (Fachinformation Chapter 4.3)

Design outcomes

Primary

Measure	Time frame
FEV1, symptom score assessment	within 3 months

Secondary

Measure	Time frame
Handling of the metered-dose inhaler, safety and tolerability	within 3 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026